Fazio V - Search Results

1

Hepatitis C and immigration: a multicentre study.

Scotto G, Armignacco O, Starnini G, Francavilla R, Foti G, Portelli V, Mazzeo M, Minerva N, Carretta V, Lo Muzio L, Fazio V. Scotto G, et al. Among authors: fazio v. Infez Med. 2016 Sep 1;24(3):210-6. Infez Med. 2016. PMID: 27668901 Free article.

2

Interferon-alpha (IFN alpha) daily dose versus IFN alpha plus ribavirin for treatment-naive chronic hepatitis c patients infected by genotype 1b.

Scotto G, Campanozzi F, D'Adduzio A, Grimaldi M, Fazio V. Scotto G, et al. Among authors: fazio v. BioDrugs. 2003;17(4):281-6. doi: 10.2165/00063030-200317040-00007. BioDrugs. 2003. PMID: 12899645 Clinical Trial.

3

[Mixed cryoglobulinemia in HCV mono-infected and HCV/HIV co-infected patients].

Scotto G, Cibelli DC, Palumbo E, Sarracino A, Fazio V, Conte PE, Angarano G. Scotto G, et al. Among authors: fazio v. Infez Med. 2004 Jun;12(2):101-7. Infez Med. 2004. PMID: 15316295 Free article. Italian.

4

Treatment of genotype 1b HCV-related chronic hepatitis: efficacy and toxicity of three different interferon alfa-2b/ribavirin combined regimens in naive patients.

Scotto G, Fazio V, Palumbo E, Cibelli DC, Saracino A, Angarano G. Scotto G, et al. Among authors: fazio v. New Microbiol. 2005 Jan;28(1):23-9. New Microbiol. 2005. PMID: 15782623 Clinical Trial.

5

Clinical and virological response to adefovir dipovixil for lamivudine-resistant HBeAg-negative hepatitis B.

Scotto G, Palumbo E, Fazio V, Tartaglia A, Saracino A, Angarano G. Scotto G, et al. Among authors: fazio v. New Microbiol. 2005 Jul;28(3):193-7. New Microbiol. 2005. PMID: 16240690 Clinical Trial.

6

Efficacy and tolerability of lamivudine alone versus lamivudine plus alpha-interferon for treatment of chronic active hepatitis B in patients with a precore-mutant variant.

Scotto G, Palumbo E, Fazio V, Cibelli DC, Saracino A, Angarano G. Scotto G, et al. Among authors: fazio v. Infez Med. 2006 Sep;14(3):145-51. Infez Med. 2006. PMID: 17127828 Free article. Clinical Trial.

7

Early and sustained virological response in non-responders with chronic hepatitis C: a randomized open-label study of pegylated interferon-alpha-2a versus pegylated interferon-alpha-2b.

Scotto G, Fazio V, Fornabaio C, Tartaglia A, Di Tullio R, Saracino A, Angarano G. Scotto G, et al. Among authors: fazio v. Drugs. 2008;68(6):791-801. doi: 10.2165/00003495-200868060-00005. Drugs. 2008. PMID: 18416586 Clinical Trial.

8

Peg-interferon alpha-2a versus Peg-interferon alpha-2b in nonresponders with HCV active chronic hepatitis: a pilot study.

Scotto G, Fazio V, Fornabaio C, Tartaglia A, Di Tullio R, Saracino A, Angarano G. Scotto G, et al. Among authors: fazio v. J Interferon Cytokine Res. 2008 Oct;28(10):623-9. doi: 10.1089/jir.2007.0116. J Interferon Cytokine Res. 2008. PMID: 18778199 Clinical Trial.

9

Prevalence of Plasmodium spp. in malaria asymptomatic African migrants assessed by nucleic acid sequence based amplification.

Marangi M, Di Tullio R, Mens PF, Martinelli D, Fazio V, Angarano G, Schallig HD, Giangaspero A, Scotto G. Marangi M, et al. Among authors: fazio v. Malar J. 2009 Jan 12;8:12. doi: 10.1186/1475-2875-8-12. Malar J. 2009. PMID: 19138412 Free PMC article.

10

QuantiFERON-TB Gold In-Tube test (QFT-GIT) for the screening of latent tuberculosis in recent immigrants to Italy.

Saracino A, Scotto G, Fornabaio C, Martinelli D, Faleo G, Cibelli D, Tartaglia A, Di Tullio R, Fazio V, Prato R, Monno L, Angarano G. Saracino A, et al. Among authors: fazio v. New Microbiol. 2009 Oct;32(4):369-76. New Microbiol. 2009. PMID: 20128443 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

947 results

Search Page

Filters